


Welcome to the May 2012 homepage edition of i2P-Information to Pharmacists. Rollo Manning has been having some time out having staples removed from the site of his open heart surgery.He is now at home recuperating in Darwin, having arrived home last Friday, beating a cold and hasty retreat from Canberra.We all wish him a speedy recovery and hopefully, he will be fit enough to contribute by next month.
This month, Pharmedia discusses the toll that is taken when someone complains about you to an authority without good cause. Well, the good news is that you can now take action to protect yourself if such a complaint is made, and that may even include action for defamation. Read about a recent case involving two doctors, with Mark Coleman drawing on personal experience to illustrate.
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
![]() | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
US scientists have uncovered a defence mechanism in bacteria that allows them to fend off the threat of antibiotics. Source: BBC News - Health
It is hoped the findings could help researchers boost the effectiveness of existing treatments.
http://news.bbc.co.uk/2/hi/health/8248020.stmAntibiotic resistance clue found
The study published in Science found that nitric oxide produced by the bacteria eliminates some key effects of a wide range of antibiotics.
One UK expert said inhibiting nitric oxide synthesis could be an important advance for tackling tricky infections.
Antibiotic resistance, for example with MRSA, is a growing problem and experts have long warned of the need to develop new treatments.
“ Here, we have a short cut, where we don't have to invent new antibiotics ”
Dr Evgeny Nudler, study leader
The latest research, done by a team at New York University, showed that in bacteria the production of nitric oxide - a small molecule made up of one nitrogen and one oxygen atom - increased their resistance to antibiotics.
They found the enzymes responsible for producing nitric oxide were activated specifically in response to the presence of the antibiotics.
They also showed that nitric oxide alleviates damage caused by the drugs as well as helping to neutralise many of the toxic compounds within the antibiotic.
The researchers then showed that eliminating nitric oxide production in the bacteria allowed the antibiotics to work at lower, less toxic doses.
More effective
Study leader, Dr Evgeny Nudler, said developing new medicines to fight antibiotic resistance, such as that seen with MRSA is a "huge hurdle".
"Here, we have a short cut, where we don't have to invent new antibiotics.
"Instead we can enhance the activity of well-established ones, making them more effective at lower doses.
Dr Matthew Dryden, consultant in microbiology and communicable disease at Royal Hampshire County Hospital and general secretary of the British Society for Antimicrobial Chemotherapy, said if the enzyme which creates nitric oxide could be inhibited, it could suppress the ability of the bacteria to counteract antibiotics.
"This would be a useful therapeutic advance, especially as we are running out of new classes of antibiotics and there is less antibiotic development in general."
Story from BBC NEWS:
Return to home
Dr Richard Hallinan B Med FAChAM (RACP): X-Concord 2012 Seminar Summary - “Benzodiazepines and dependence”, with an emphasis on people on opioid pharmacotherapies | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Taking care of pharmacists’ health – what is it worth? | open full screen
Neil Johnston: An Evidence-Based Conversation Between Ken Harvey, Gerald Quigley and Neil Johnston | open full screen
Neil Johnston: An Evidence-Based Conversation Between Ken Harvey, Gerald Quigley and Neil Johnston- Part 2 | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Tax time – a donation to PSS is a gift to your profession and a deduction for you | open full screen
Neil Retallick: Good news for community pharmacy from the Minister of Agriculture | open full screen
Dr Ian Colclough: While doctors remain disempowered doctor shoppers needing help will die. | open full screen
If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment